Your basket is currently empty!
A6KB40 (RAT)
Like A6KB40 (RAT) Antibodies, Ankyrons® that detect A6KB40 (RAT) can be used in several scientific applications, including ELISA, Western Blot, Flow Cytometry, Immunofluorescence and Immunohistochemistry. Like antibodies these Ankyrons target A6KB40 (also known as Dll1 rCG_22926) in Rattus norvegicus (Rat) samples.
Our A6KB40 (RAT) Monomer Ankyrons are developed in vitro in ribosome display. These Ankyrons have been verified by ELISA to confirm specificity to A6KB40 (RAT). Find the A6KB40 (RAT) Ankyron that fits your needs with 6 A6KB40 (RAT) Ankyron clone(s) available in our catalogue. Validation data can be viewed with 6.0 image(s) featured in our data gallery.
A6KB40 is also commonly referred to by the following: Delta-like protein
| Allele | Peptide Code | Peptide Sequence | Application | Epitope Origin |
|---|---|---|---|---|
-- All Alleles -- A*02:01 B*08:01 A*01:01 A*24:02 A*11:01 B*27:05 B*40:01 B*15:01 B*07:02 B*35:01 H-2Ld A*03:01 H-2Db H-2Kd H-2Kb E*01:01 DRA1*01:01/DRB1*01:01 DRA1*01:01/DRB1*03:01 DRA1*01:01/DRB1*04:01 DRA1*01:01/DRB1*07:01 DRA1*01:01/DRB1*11:01 DRA1*01:01/DRB1*15:01 DRA1*01:01/DRB1*04:02 DRA1*01:01/DRB1*09:01 DRA1*01:01/DRB1*03:01 DRA1*01:01/DRB1*04:05 H-2 IAb H-2IAb Mamu-A*02 Mamu-A*01 H-2Dd H-2Dk A*68:01 H-2Kk A*29:02 A*02:01/Kb A*02:03 A*02:06 A*11:03 B*14:02 B*35:08 B*54:01 C*06:02 C*07:02 H-2IAd H-2IAg7 H2-Kd DRB1*03:01 DRB1*01:01 DRB1*15:01 H-2 IAd DRA1*01:01 / DRB1*15:01 DRA1*01:01 / DRB1*07:01 DRB1*07:01 DRA1*01:01 / DRB1*04:01 A*30:01 A*68:02 B*44:03 B*51:01 B*57:01 B*58:01 C*02:01 C*03:03 C*05:01 C*07:01 C*08:01 E*01:03 A*23:01 A*02:07 A*26:01 A*29:01 A*30:02 A*33:03 B*13:02 B*15:03 B*18:01 B*44:02 B*46:01 B*49:01 B*57:03 C*01:02 C*03:02 C*03:04 C*04:01 A*02:02 | -- All Peptide Codes -- 405 489 366 76 527 683 648 639 874 840 739 1072 42 8 414 380 308 45 114 21 125 249 85 210 46 214 199 420 44 73 190 7 77 9 119 98 32 27 23 28 31 377 378 413 422 129 3 2 40 35 415 95 84 246 10 174 109 194 419 196 257 193 195 294 176 958 324 276 133 1181 353 338 391 56 561 188 185 62 154 1013 600 86 82 404 389 57 302 171 205 208 212 390 97 250 157 75 118 264 87 230 421 209 417 418 94 150 813 560 329 859 810 690 117 1056 915 712 2739 N02A N02B N02C N02D N02E N02F 357A 2717 357B 2729 2705 357C 357D 2738 1940 2702 2735 2723 1126 2721 2720 1942 2741 2742 2718A 2706 2718B 2718C 2691 2699 2722 2690 2703 549 2693 2715 2727 2737 2714 2719 2740 2728 2716 2734 2701 1912 2736A 2712 2733 2736B 479 357F N02I 2712A 2712B 2902 2883 2884 822 2882 2900 2901 2896A 2896B 2896C 2897 1941 2899 2898A 2898B 2894A 2892 2888 2889 2890 2891 2894B 2893 2895 1945 2887 2725 2707 2736C N02G 3137 3135 3166 3136 3164A 3164B 2898C 3152 3139 3134 3153B 3153A 3147 3131 3163A 3163B 3163C 3163D 3163E 3163F 3165 3161 3151 3145 3138 3148 3146 3132 3144 3157 3133 3143 3167 3140 3159 3158 3115 3149 3162 2963 3155 3156 3215 357E N02H 3242A 3242B 3243A 3243B 3243C 3244A 3244B 3955 082 049 008 4129 4250 2951 4295 4683A 4683B 4683C 646 34 394 666 508 283 740 491 4 742 565 120 773 581 1153 828 488 149 458 1152 689 727 1112 1111 1110 781 266 1599 1598 278 645 692 N01 599 1431 1066 1094 242 172 36 845 721 942 939 791 686 684 989 151 954 851 393 470 200 1043 70 69 186 178 771 314 376 175 1113 328 327 93 908 74 198 801 964 708 158 769 547 978 703 622 373 1320 1327 1322 663 1182 447 814 430 799 411 255 1211 1722 1720 1743 1744 540 463 339 398 1904 1403 2079 2083 2199 61 238 307 343 468 695 1731 1201 1333 1386 1464 1920 2291 2299 2303 2313 399 409 2305 477 858 177 877 1684 502H 2064 2065 2312 2076 473 1803 562 764 733 2293 2302 4356A 1786 2294 351 2296 2297 2298 381 2304 2307 541 654 1806 49 2311 47 2300 2301 48 2292 37 2306 2309 2295 2308 2310 1 240 2355 3240 658 611 610 142 2290 2697 395 2156 620 619 2221 1263 995 2097 1346 685 2206 2259 1107 1780 237 860 1509 3239 2585 893 29 30 861 58 559 2695 163 2988 2369 841 862 2103 2755 3403 575 1421 780 2990 2754 2198 464 127 2167 2205 1838 726 462 410 871 1805 3238 403 1486 879 719 1686 1496 1778 3343 3342 1508 3344 3345 3346 3347 3348 3349 485 3350 231 3351 1064 3352 3353 3380 3354 4320 3355 3356 3357 3358 424 3359 3360 3361 811 3362 3363 3364 3365 3366 3367 480 3368 1908 3369 3370 3371 552 615 1937 202A 202B 202C 3372 3373 3374 3375 3376 3377 452 774 3379 3381 3382 3383 2371 3398 3384 3385 3386 2081 1239 594 3387 3388 1910 3389 3390 3391 144 2382 3394 3033 1616 647 872 107 652 269 3781 2829 1240 1147 3392 3396 3401 3402 1536 3404 2560 2067 3405A 3405B 3406 3407 3408 3400 3409 3410 3411 3412 1915 2331 3414 3415 886 651 3397 3416 960 884 628 2282 543 1303 550 3418 3419 3420 3421 3422 162 164 220 221 226 243 304 306 334 335 337 345 370 408 457 467 500 516 526 529 580 637 655 662 693 701 752 778 785 787 921 922 969 997 998 2858 1513 3423 2070 2954 3910A 3910B 3934 3935 3937 3939 3941 1194 2659 3041 1324 1321 3942 3903 1783 3943 3945 3094 3947 3264 3744 3269 2373 3906 1843 2372 3907 3908 3909 3912 3913 3914 3915 3929A 3929B 3918 3916A 3916B 3923 3924 3925 2929 3928 3921A 3921B 3931 3623 3624 3626 3627 3628 3630 1542 3632 3633 3634 2102 3636 3638 2582 1779 3641 1302 3643 3644 3647 3648 3649 2236 2669 3654 3655 3656 1246 3658 3659 3660 3661 3662 1007 3666 3668 3669 3670 3671 2793 3673 3674 3675 3678 3680 3681 3684 3436 3687 3688 3689 3691 3693 3695 3696 3698 3699 3702 3704 3705 3706 3708 3709 3710 3711 2457 3713 3715 2649 3718 3719 3720 3721 3722 3723 3724 3725 3726 2569 3728 1130 3730 3731 3732 3733 3734 3735 3736 3622 1516 3214 4342 4418 4355 4351 4356B 4354 4501 2257 2164 4549 3459 3460 3461 4625 4626 4627 4628 4629 4630 4631 4632 4083 4082 4081 4633 3006 4381 4382 4321 4322 4323 4324 4326 4339 4328 4358 2778 2860 3080 3417 2675 3070 3072 2194 2415 3462 4183 3051 4340 4679 4544 2950 3043 3092 2844 4333 4894 4404 4122 4123 4124 4125 3028 3223A 3024 3223B 2958 4131 N02J N02K N02L N02M 4132 4133 3027 4135 4136 4137 423 4118 4119 3029 3023 4294B 4273 4272 4702A 4294A 4271 4270 4269 4268 4187 4186 1010 4332 4331B 4331A 4330 4329 4702B 4702C 4703A 4703B 4703C 4704A 4704B 4704C 4705A 4705B 4705C 4690 4691A 4691B 4692 4668 4694 4443 4407 4406 4405 4414 1244 4670 4724 4725 4726 4634 001 002 003 004 007 009 010 021 023 027 028 029 030 031 032 034 035 036 037 040 042 044 045 046 047 048 056 057 058 061 062 069 070 073 074 075 076 077 084 085 086 087 093 094 095 097 098 3099 | -- All Peptide Sequences -- KLQCVDLHV QAKWRLQTL LMWYELSKI CTELKLSDY ALYVDSLFFL TYGPVFMSL PYLFWLAAI ATIGTAMYK KRWIIMGLNK KEKGGLEGL VTEHDTLLY RLRPGGKKKY CLGGLLTMV NLVPMVATV QYDPVAALF VYALPLKML RPHERNGFTVL TPRVTGGGAM IPSINVHHY YPHFMPTNL GVLVGVALI HLSTAFARV ILAKFLHWL ILHNGAYSL IMDQVPFSV KIFGSLAFL IVTDFSVIK TYGPVFMCL RPPIFIRRL FLRGRAYGL RAKFKQLL GILGFVFTL ILRGSVAHK ASNENMDAM ASNENMETM TYQRTRALV FLLSLGIHL FLLTRILTI FLPSDFFPSV GLSPTVWLSV WLSLLVPFV YVNVNMGLK EYLVSFGVW KYTSFPWLL ILSPFLPLL IPQSLDSWWTSL CINGVCWTV DLMGYIPAV KLVALGINAV RVCEKMALY AYSQQTRGL YMLDLQPETT ILKEPVHGV KLTPLCVTL SLYNTVATL TLNAWVKVV QVPLRPMTYK RLRPGGKKK RYLKDQQLL IPRRIRQGL TPGPGVRYPL FLKEKGGL GEIYKRWII KRWIILGLNK AMQMLKETI SLVDVMPWL GLPVEYLQV KLIANNTRV LLDVPTAAV SLSEKTVLL RILGAVAKV QLCPICRAPV LMLGEFLKL FAPGNYPAL TMNGSKSPV SSIEFARL SVYDFFVWL RYLKNGKETL SYIGSINNI FLGYLILGV ALFDIESKV ALQPGTALL ELAGIGILTV FLTPKKLQCV GLYDGMEHL KTWGQYWQV KVAELVHFL KVLEYVIKV LLGRNSFEV LLLLTVLTV RLLQETELV SLLMWITQV VISNDVCAQV VLQELNVTV VLYRYGSFSV YLSGANLNL ALLAVGATK ATGFKQSSK KQSSKALQR AFLPWHRLF TFPDLESEF TYACFVSNL TYLPTNASL VYGFVRACL GFKQSSKAL LPYLGWLVF FVGEFFTDV GLMEEMSAL ILLWQPIPV KLQDASAEV LIAHNQVRQV LLHETDSAV RLVDDFLLV SLFLGILSV TLPGYPPHV VMAPRTLIL LCWGELMTLATWVGVN PVSKMRMATPLLMQA PKYVKQNTLKLAT SGPLKAEIAQRLEDV GFVFTLTVPSER FWRGENGRKTRIAYERMCNILKGK TSLYNLRRGTALA TVFYNIPPMPL AEGLRALLARSHVER PGPLRESIVCYFMVFLQTHI VPGLYSPCRAFFNKEELL LPLKMLNIPSINVH PDDYSNTHSTRYVTV EPDVYYTSAFVFPTK MSIYVYALPLKMLNI DYVDRFYKTLRAE KRWIILGLNKIVRMYSPTSI FRDYVDRFYKTLRAEQASQE AFSPEVIPMFSALSEGATPQ QAGFFLLTRILTIPQS PPAYRPPNAPILSTL LSFLPSDFFPSVRDL TLLFNILGGWVAA VYYLTRDPTTPLARAA GYKVLVLNPSVAATL SGIQYLAGLSTLPGNPAIASL NFPYLVAYQATVCARA GINAVAYYRGLDVSV PIVQLQGDSNCLKCFR KELKRQYEKKLRQ FNNFTVSFWLRVPKVSASHLE QYIKANSKFIGITEL KFIIKRYTPNNEIDSF VSIDKFRIFCKALNPK GAGSLQPLALEGSLQKRG IAFTSEHSHFSLK DENPVVHFFKNIVTPRTPP LLEFYLAMPFATPME LKEFTVSGNILTIRL ACYEFLWGPRALVETS WNRQLYPEWTEAQRLD GEEYLILSARDVLAV VYGGSKTSLYNLRRGTALAI PRSPTVFYNIPPMPLPPSQL PYYVVDLSVRGM GQTYHLIVDTDSLGNPSLSV MHVSFVMAYPEMLAA MSQIMYNYPAMMAHA EYLNKIQNSLSTEWSPCSVT GIVEQCCTSICSLYQ NFIRMVISNPAAT YESYKFIPALEAAVK ETLLRAVESYLLAHS KVPIKWMALESILRRRF IYRRRLMKQDFSVPQLPHS ESEFQAALSRKVAKL LTQYFVQENYLEYRQVPG YACFVSNLATGRNNS NYTLRVDCTPLMYSL ALHIYMDGTMSQVQGSA RNGYRALMDKSLHVGTQCALTRR ISPNSVFSQWRVVCDSLEDYD TSYVKVLHHMVKISG AKRLDACQDQLLE GQIGNDPNRDIL DSVTPMILKAQKGGNL AYCLWMMLLISQAEAALELIT WPLLLLLLALPQRAYAQ DRVNFKYSFSVIE VGLLKAVESYLLA LPVVLENARILKNCVDAK ELEKYQQLNSERGVPN AVNIVGYSNAQGVDY LRQMRTVTPIRMQGG KCIEWEKAQHGA APYHFDLSGHAFG VAAAPQVKYAVFEAALTKAI VVNKGTGNLELVAVRKEQQQ TSRNNPFYFPSRRFSTRYGN LEAAFNAEFNEIRRVLLEEN HTYTIDWTKDAVTWS DVMNILLQYVVKSFDRSTKV KGMAALPRLIAFTSEHSHFS IFDS[cit]GNPTVEVDLF ATEG[cit]V[cit]VNSAYQDK GVYAT[cit]SSAV[cit]L[cit]SSVPGVR QDFTN[cit]INKLKNS ATIKAEFV[cit]AETPYM GKLYGI[cit]DV[cit]STRDR YYSNVTATRLLSSTNS ENIQRFLPNPAGVQLEDPEF RQIFGDYKTTIC QEIYMQHTYPISA MAKTIAYDEEARR KTIAYDEEARR TWTTCQSIAFPSKTSASIGS RTELLKDAIGEGK MEAIAKRLDACQDQLLELYE MTEQQWNFAGIEAAA LWWVNNQSLPVSP WVKQTPGRGLEWIGA SSPKPWIYATSNLAS EWVAEIRSKSINSAT GEPGIAGFKGEQGPK SLLMWITQC AKFVAAWTLKAA EISTNIRQAGVQYSR SLQPLALEGSLQSRG SLTITSLLRRHNWITSCS TRFQTLLALHRSYLT KLFGTSGQKT FLWGPRALV YLFFYRKSV FLYALALLL SSCSSCPLSK FLPSDFFPSI ATDALMTGY DLMGYIPLV YLLPRRGPRL GPRLGVRAT HPNIEEVAL SSLENFRAYV VLPLTVAEV RTLDKVLEV QLFNHTMFI KSPWFTTL VVYDFLKL KYKNAVTEL KYNKANVFL VLMIKALEL VLAGGFFLL RLRAEAQVK GSENLKSLY YTSGPGIRY CTPYDINQM VLDGLDVLL YSEHPTFTSQY KLGGALQAK VLAELVKQI AGPPRYSRI YLNTVQPTCV IEDPPFNSL NEGATIVE ALDVYNGLL MGLKFRQL ATDALMTGF GLQDCTMLV KLSGLGINAV LLFNILGGWV VLSDFKTWL DPRRRSRNL HSKKKCDEL CPNSSIVY REISVPAEIL GAVQNEVTL TDLGQNLLY TYFSLNNKF KPYSGTAYNAL KLQVFLIVL LNIDLLWSV HLVEALYLV VMNILLQYV SLSRFSWGA LLFGYPVYV SFHSLHLLF FQPQNGQFI KAVYNFATC SGVENPGGYCL GYKDGNEYI YYIPHQSSL YLNKIQNSL SYIPSAEKI FIDSYICQV SPSVDKARAEL KCSRNRQYL WMHHNMDLI SIINFEKL KVVRFDKL TPHPARIGL HYLSTQSAL KMLKEMGEV VNHRFTLV ANYNFTLV MPVGGQSSF IMYNYPAML AIQGNVTSI ILDDNLYKV KVDDTFYYV MPYLIDFGL RGYVYQGL RLDDDGNFQL YTMDGEYRL ATWAENIQV LGMSNRDFL ATLTYRML YLQVNSLQTV EYILSLEEL GLADQLIHL LTFGWCFKL RYPLTFGWCY NPDIVIYQY VPLDEDFRKY KSMREEYRK RMVLASTTAK QPEWFRNVL SPIVPSFDM VSDGGPNLY SRYWAIRTR RRLGRTLLL SPSYVYHQF VLFGLGFAI VIMPCSWWV FLYDDNQRV FLAEDALNTV FSNSTNDILI YMDGTMSQV VYFFLPDHL KSDICTDEY TYVPANASL ILSLELMKL Abu-Abu-L-Abu-LTVFL ATFKNWPFL YMCSFLFNL KVPRNQDWL GLAPPQHLIRV LTLGEFLKL ALLTSRLRFI AILALLPAL SLPPPGTRV CYASGWGSI HGIRNASFI EPLPQGQLTAY YLLEMLWRL QPRAPIRPI VWLSVIWM CVNGVCWTV RGPGRAFVTI GPGHKARVL IGPGRAFYA RAHYNIVTF KLCLRFLSK KPTLKEYVL MLDLQPETT ISHNFCNL VLHDDLLEA SIYRYYGL LTFNYRNL IMYNYPAM TSYKFESV GLQHWVPEL AYACNTSTL KTFPPTEPK GLLGASVLGL GVRGRVEEI HNTQYCNL ITDQVPFSV KLCPVQLWV KVAEELVHFL LLLTVLTVV LPWHRLFLL MPFATPMEA RISTFKNWPK RMPEAAPPV RYCNLEGPPI TVSEFLKL YLEPGPVTV YLGSYGFRL YLQLVFGIEV YLSGADLNL FLDKGTYTL ALYDVVTKL GRAFVTIGK AVLDGLLSL ILGFVFTLTV ALPHIIDEV YLVSIFLHL GLCTLVAML IYSTVASSL VMAPRTLVL VYDFAFRDL KLPQLCTEL ILMWEAVTL SITEVECFL KAVYNFATM SYVPSAEQI SQLLNAKYL YIGEVLVSV SVLAFRRL AMASTEGNV GILTVSVAV VLTDGNPPEV VYAGAMSGL ALWALPHAA LLWNGPMAV IPYLDGTFY KPYSGTAYNSL SGPSNTPPEI ALWGPDPAAA RSPFSRVVHL HCIRNKSVIL IMPKAGLLI SLYSFPEPEA TLADFDPRV TPNQRQNVC VGRNFTNL VLDFAPPGA EADPTGHSY EVDPIGHLY SLLQHLIGL YLEPGPVTA HCIRNKSVI ASMTNMELM FMNKFIYEI RVA(PHOSPHO-S)PTSGV EPR(PHOSPHO-S)PSHSM LLLIWFRPV VIFDFLHCI YMLDLQPET AQLANDVVL VIYHYVDDL GVYDGREHTV KVVEFLAML QLFEELQEL RVASPTSGV SIIVFNLL VILTNPISM YMNGTMSQV ELRRKMMYM LGPISGHVL MLNIPSINV RVRAYTYSK AVFDRKSDAK YVLDHLIVV YLQQNWWTL ARMILMTHF RYLRDQQLL RYPLTFGW AMQMLKDTI AVDLSHFLK EIYKRWII AAVKNWMTQTL ACQGVGGPGHK AIFQSSMTK ALMEQQHYV ALNVYNGLL YTCPLCRAPV ALPFGFILV ALSPVPPVV ALVCYGPGI ALWPWLLMAT ALYLMELTM APRGVRMAV ASFRNLTHL AYIDFEMKI CLPSPSTPV CMTWNQMNL DYLNEWGSRF DYLQYVLQI ELSDSLGPV EYCPGGNLF EYRALQLHL EYYELFVNI LLLDRLNQL FLFLRNFSL FLPSPLFFFL GLFKCGIAV GLIQLVEGV GRFGLATEK GRFGLATVK GYCTQIGIF ILGVLTSLV ILHDGAYSL IYTWIEDHF LLVPTCVFLV LPVSPRLQL MLAVFLPIV NLFETPVEA NYQPVWLCL PLFDFSWLSL QLGEQCWTV QLLDGFMITL QVLKKIAQK RIAAWMATY RLAEYQAYI RLGLQVRKNK RLLFFAPTR RLSSCVPVA RMFPNAPYL RYNAQCQETI SDYYFSWL SIDWFMVTV SILLRDAGLV SKYVFENV SLFEPPPPG SLGEQQYSV SLLFLLFSL SQADALKYV SYMLQALCI SYRNEIAYL TLDTLTAFY TLQDIVYKL TVSGNILTIR VYLRVRPLL VYYNWQYLL WLSLKTLLSL YLIELIDRV YLISGDSPV YLNDHLEPWI YLNRHLHTWI YLQWIEFSI YLVGNVCIL YLYQWLGAPV AYAQKIFKI ELKRKMIYM VLEETSVML MVWESGCTV VIVMLTPLV HPVAEADYFEY LLDFVRFMGV RPQGGSRPEFVKL TLDYKPLSV YPLHEQHGM IVDCLTEMY TENSGKDI LLMWEAVTV KLHLYSHPI ALVEMGHHA FLGKIWPS LYNTVATLY SFNCRGEFFY SLFNTVATL SLVKHHMYI YLKDQQLL AGVDNRECI EVYDFAFRDL NTLEQTVKK AGPHNDMEI QMARLAWEA TYWPVVSDI GLLSLEEEL LPVSCPEDL KLGEFYNQMM SCLENFRAYV SLNQTVHSL CYYASRTKL TVYGFCLL TSINFVKI IYNVGQVSI TEWETGQI SADNNNSEY VPQYGYLTL KEKYIDQEEL KLMSSNSTDL RLMNDMTAV RLWQELSDI LLAARAIVAI FLDPRPLTV ALCNTDSPL LLFGLALIEV ALKDVEERV STLCQVEPV VLQMKEEDV AIQDLCLAV QLLIKAVNL AIQDLCVAV PLFQVPEPV GLSPNLNRFL LLLLDVAPL LLDVAPLSL HLYQGCQVV KLSGLGLNAV VLAGVGFFI FLYTLLREV RLNMFTPYI NMFTPYIGV RLQEERTCKV VLGEAWRDQV TIHDIILECV TLAPATEPA SLEENIVIL KCDICTDEY VLHKRTLGL LLGATCMFV SYVNTNMGL WYWGPSLYSI VYLKTNVFL SLAMLDLLHV KLVVVGADGV PLTSIISAV VMAGVGSPYV LPSDFFPSV KLVVVGAVGV GLSRYVARL VVGAVGVGK RLASFYDWPL YMEHNNVYTV YLQHNEIQEV RLLPLLALL RLARLALVL FLTGNQLAV FHTYTIDWTKDAVTW SIIPSGPLK ALTPVVVTL LPLMRKAYL QYSDRRWCF RVSTVQQLTK ELMTLATWV FFPSIRDLL GLKILQLL LLDTASALY STLPETTVVRR YMDDVVLGA YVNTNMGLK ILEDIVLTL SLFGQRIEV SVGGVFTSV TRRFLPQIL CLLPKMDSV FLHCIVFNV ASFVNPIYL NRAKQVIKL ARKLLLDNL SAVSNLFYV TRATKMQVI QIKVRVDM CRVLCCYVL GTSGSPIVNR GTSGSPIVDR GTSGSPIINR GTSGSPIIDK GTSGSPIADK TPEGIIPTL APTRVVAAEM CLIPTAMAF ELERAADVK ILIRTGLLVI RIKQKGIL KITAEWLWK AIKRGLRTL RIEPSWADVK LLLGLMILL GEARKTFVEL LEKTKKDL TLYAVATTI VLLLVTHYA RVIDPRRCMK KLAEAIFKL DSDPDSFQDY EADPIGHLY EVDPASNTY HSTNGVTRIY ILDTAGREEY LVDVMPWLQY QSLEIISRY RSDSGQQARY VTEPGTAQY VYDFFVWLHY YVDFREYEYY AILALLPALL ALIHHNTHL ATVGIMIGV CLTSTVQLV CMHLLLEAV FLAKLNNTV FLIIWQNTM FLPWHRLFLL FVWLHYYSV GLFGDIYLA GLFGDIYLAI GLMKYIGEV GVLLWEIFSL ILLRDAGLV ILLVVVLGV ILNAMIAKI KASEKIFYV KASEYLQLV KIWEELSVL KLIDRTE(S)L KLTGDENFTI LLCYSCKAQV LLLAGLFSL LLLEAVPAV LLNQLQVNL LLRDAGLVKM LLRRYNVAKV LLSHGAVIEV LMAQEALAFL LVFGIELMEV LVFGIEVVEV MLWGWREHV PLQPEQLQV QLMAFNHLI QLMPYGCLL RLGPTLMCL RLQGISPKI RLTRFLSRV RTF(S)PTYGL SILLRDAGL SLADEAEVYL SLDDYNHLV SLYKFSPFPL SMTR(S)PPRV TLEEITGYL TLHCDCEIL VLEPPGARDV VLLALLMAGL VLSVNVPDV VLVKSPNHV VMIG(S)PKKV VVLGVVFGI WLPKILGEV WLQYFPNPV YAIDLPVSV YLLDLSTNHL YLWWVNNQSL YVDPVITSI ALGGHPLLGV ALLAGLVSL ALLTYMIAHI ALMDKSLHV ALPPPLMLL ALSVMGVYV ALVEFEDVL ALWPWLLMA AMLGTHTMEV AMVGAVLTA AVIGALLAV AVLPLLELV CLYGNVEKV DLIFGLNAL ELFQDLSQL FAWERVRGL FIASNGVKLV FLALIICNA FLDEFMEGV LTDDRLFTCY AITEVECFL TMFPHIIVDV LLYDANYFL KLWAQCVQL FTSDYYQLY SPRWYFYYL QRNAPRITF CTDDNALAYY LLYNCCYHV HPRLAQRIL SIIAYTMSL ATYGWNLVK STYGWNIVK STYGWNLVR GTSGSPIVDK GTSGSPIINK TIPPTAGILK TTLSRTSKK KTFDSEYVK KTFDSEYIK KTFDTEYQK ATVLMGLGK RYLEFEALGF TYGWNLVKL TYGWNLVRL TYGWNIVKL TYFQRVLIF KVDELAHFL TTDPSFLGRY PTDNYITTY FIAGLIAIV ALNTLVKQL LITGRLQSL NLNESLIDL VLNDILSRL YLQPRTFLL MEVTPSGTWL RLQSLQTYV GLSNLTHVL ALLPAVPSL KVLEHVVRV SLYSYFQKV STHVNHLHC VVVGADGVGK VVVGAVGVGK YLNPSVDSV YSSDNLYQM FMVFLQTHI SSCSSCPLTK LPNWGKYVL KIADYNYKL SVYAWNRKR VVLSFELL SLQPLALEGSLQKRG TVYGAFDPLLAVAD GWVKPIIIGHHAYGDQYRAT KSVWSKLQSIGIRQH TLFFQNGKVKVFQGNQDSFT AHHPIWARMDA CTFEYVSQPFLMDLE TMFEALPHIIDEVIN CDMLRLIDYNKAALS PSLTMACMAKQSQTP SQNRKDIKLIDVEMT NEKYAQAYPNVS AAHAEINEA EAWGALANWAVDSA GWYRSPFSRVVH TTHYGSLPQKSQ PVSQMRMATPLLMRP NKGAFKYIKPQSQFI NYFEWPPHALLVRQ FQDAYNAAGGHNAVF KAAGLFNAPASQLAR MTEQQWNFAGIEAAASAIQG PVGRLVTVNPFVSVA NAGFNSNRANSSRSS TASSYFTNMFATWSPSKARL GNAYISVLAHYGKNG QVYSLIRPNENPAHK DIYKGVYQFKSV TTVRLRAYMNTPGLPVC SPGDLQTLALEVARQKRG SERPQASGVYMGNLT FYVYSRVKNLNSSRV KNVLKVGRLSAEELM SLLTEVETPIRNEWGS RGHNVNGVTAACSHE HNTNGVTAACSHE GWYRSPFSRAVH GWYRPPFSRVVH ISQAVHAAHAEINEAGR QALNTLVKQLSSNFGAI QLIRAAEIRASANLAATK MAYRFNGIGVTQNVLY GAALQIPFAMQMAYRF LEASFNYLKSPNFSK LSYYKLGASQRVAGD SEFSSLPSYAAFATA HTTDPSFLGRY VTNNTFTLK NYNYLYRLF QYIKWPWYI RARSVSPKL KCYGVSPTK TSRTLSYYKLGASQRVA TDEMIAQYTSALLAG NLLLQYGSFCTQLNR NLLLQYGSFCTQLNRAL NVWATHACV VYIGDPAQL KLFAAETLK TLVPQEHYV IVDTVSALVY RYPLTFGWCF | -- All Applications -- Cancer EBV Other Influenza HIV/SIV CMV HBV HCV HPV Tuberculosis Sendai Virus HSV RSV Human Mouse Negative HIV Tetanus Autoimmunity Malaria Allergy Aspergillus Bordatella Pertussis Factor VIII Multiple Sclerosis Therapeutic Antibodies Model Antigens / Other COVID-19 / SARS-CoV-2 Minor Histocompatibility Antigen MuLV SV40 Virus Adenovirus HTLV LCMV Listeria Model Antigens Trypanosoma cruzi Vaccinia Virus Vesicular Stomatitis Virus West Nile Virus Yellow Fever Virus JC Virus Toxoplasma gondii Varicella Zoster Virus BK Virus AAV Chlamydia Dengue Norovirus HAV Helicobacter pylori | -- All Epitope Origins -- Prostate Specific Antigen 146-154 EBV EBNA3A 158-166 KSHVF-8 gB.492-500 Influenza A (PR8) NP 44-52 PRAME PRA 300?309 EBV LMP2 419?427 EBV LMP2 131-139 EBV BRLF1 134-142 HIV-1 Gag p24 263-272 HIV-1 Nef 92-100 HCMV pp50 245-253 HIV-1 p17 20-29 EBV LMP-2 426-434 HCMV pp65 495-504 HCMV pp65 341-349 HCMV pp65 113-121 HCMV pp65 265-275 HCMV pp65 417-426 HCMV pp65 123-131 MCMV IE1 168-176 Carcinogenic Embryonic Antigen (CEA) 694-702 G250 (renal cell carcinoma) 217-225 Telomerase 540-548 HER-2/neu 435-443 gp100 (pmel17) 209-217 HER-2/neu 369-377 EBV EBNA-4 416-424 EBV LMP-2 419-427 EBV EBNA-3A 247-255 EBV EBNA-3A 193-201 EBV BZLF-1 190-197 Influenza A MP 58-66 Influenza A (PR8) NP 265-274 Influenza A (NT60) NP 366-374 Influenza A (PR8) NP 366-374 Influenza A (PR8) NP 147-155 HBV polymerase 573-581 HBV envelope 183-191 HBV core antigen 18-27 HBV surface antigen 185-194 HBV surface antigen 172-181 HBV core antigen 88-96 HBV core 117-125 HBV polymerase 756-764 HBV surface antigen 208-216 HBV surface antigen 28-39 HCV NS3 1073-1081 HCV core 132-140 HCV NS3 1406-1415 HCV NS5B 2588-2596 HCV NS3 1031-1039 HPV 16 E7 11-20 HIV-1 RT 476-484 HIV-1 env gp120 90-98 HIV-1 gag p17 76-84 HIV-1 gag p24 19-27 HIV-1 nef 73-82 HIV-1 gag p17 19-27 HIV-1 gag gp41 67-75 HIV-1 env gp120 848-856 HIV-1 nef 128-137 HIV-1 nef 90-97 HIV-1 gag p24 261-269 HIV-1 gag p24 265-274 HIV-1 gag p24 199-207 Cytochrome p450 1B1 239-248 Mycobacterium bovis antigen 85-A 6-14 Mycobacterium bovis antigen 85-A 200-208 Interferon gamma inducible protein (GILT) 30 27-35 CD59 glycoprotein precursor 106-114 Vinculin 822-830 Livin/ML-IAP280 175-184 Survivin 96-104 Sendai virus NP 324-332 hMena 502-510 HSV-1 gp B 498-505 Tyrosinase related protein-2 180-188 HLA-Cw3 170-179 RSV M2 82-90 Prostatic Acid Phosphatase-3 (PAP-3) PSM P2 (prostate) Prostate Stem Cell Antigen (PSCA) 14-22 MelanA / MART 26-35 Prostate Specific Antigen-1 (PSA-1) 141-150 MAGEA-10 254-262 gp100 (pmel17) 154-162 MAGEA3 112-120 MAGEA1 278-286 p53 264-272 MUC-1 12-20 HER-2/neu 689-697 NY-ESO-1 157-165 Prostate Specific Antigen-1 (PSA-1) 154-163 Leukocyte Proteinase-3 (Wegener's autoantigen) 169-177 gp100 (pmel17) 476-485 Carcinogenic Embryonic Antigen (CEA) 571-579 gp100 (pmel17) 17-25 bcr-abl 210 kD fusion protein 259-269 bcr-abl 210 kD fusion protein 21-29 Tyrosinase 188-196 MAGEA3 97-105 Carcinogenic Embryonic Antigen (CEA) 652-660 HER-2/neu 63-71 Telomerase reverse transcriptase (hTRT) 461-469 bcr-abl 210 kD fusion protein 19-27 Tumour Antigen P815 35-43 GPC3 144-152 (overexpressed in hepatocellular carcinoma) Human Mena protein (overexpressed in breast cancer) Prostatic Acid Phosphatase-3 (PAP-3) 135-143 HM1.24-aa 126-134 HER-2/neu (85?94) PSMA/PSM-P1 4-12 Telomerase Reverse Transcriptase 865-873 CD20 188-196 (B cell malignancies) PAX-5 311-319 HLA-C leader sequence peptide HBV? core? 60-75 CLIP 87-101 Influenza A HA 307-319 Influenza A MP 17-31 Influenza A MP 61-72 Influenza A NP 206-229 EBV EBNA1 515-527 EBV EBNA2 280-290 EBV EBNA1 482-496 EBV EBNA1 551-570 MCP 1264-1281 pp65 116-129 gB 215-229 pp65 177-191 pp65 109-123 HIV-1 gag 295-307 HIV-1 gag 263-282 HIV-1 gag 293-312 gag 163-182 envelope 179-194 core 158-172 core 45-59 polyprotein 1806?1818 NS4b polyprotein 2800-2815 NS5b polyprotein 1248-1262 NS3 polyprotein 1770-1790 polyprotein 1582?1597 polyprotein 1411?1425 E2 285-300 BPLF1 1395-1407 TT 947-967 TT 830-844 TT 1174-1189 TT 1084-1099 Proinsulin 73-90 GAD65 274-286 Myelin basic protein 83-101 NY-ESO-1 87-111 NY-ESO-1 123-137 MAGE-A3 267-282 gp100 44-59 NY-ESO-1 87-101 Mtb 10 kDa chaperonin GroES EBNA1 509-528 EBNA2 276-295 BHRF1 122-133 EBNA2 11-30 Mtb PE family protein Mtb ESAT-6 like protein CSP 326-345 Proinsulin 90-104 GAD65 555-567 Grass pollen allergen Phl p 5 196-210 Birch pollen allergen Bet v 1 142-156 HER2 883-899 gp100 615-633 MAGE-A6 102-116 MAGE-A6 246-263 CEA 653-667 PSMA 459-473 tyrosinase 365-381 MART-1 51-73 Tyrp1 277-297 MAGE-A3 281-295 E2 5-17 EBV BNRF1 1395-1407 HPV E2 1-20 TT 1273-1284 Dog dander Can f 1 33-48 HCV NS2 732-753 HCV NS2 47-63 Alder pollen Aln g 1 76-88 Alder pollen Aln g 1 142-154 Birch pollen Bet v 1 141?155 Cat dander Fel d 1 53-70 Cow dander Bos d 2 143-158 House dust mite Der p1 251-265 House dust mite Der p1 96-110 Mugwort pollen Art v 1 25-36 Rye grass Lol p1 124-136 Timothy grass Phl p 5 p26 Peanut Ara h 1 457-476 Peanut Ara h 1 169-188 Peanut Ara h 1 321-340 Aspergillus fumigatus Asp f 9 171-185 GAD65 113-132 GAD65 265?284 cit alpha-enolase 11-25 cit aggregan 89-103 cit vimentin aa 59-78 cit fibrinogen-alpha 79-91 cit CILP 297?311 cit CILP 982?996 Pertussis toxin subunit 2 129-144 Factor VIII 589?608 PLP 98-109 Tetanus Toxin 257-269 Mtb groEL 1-13 Mtb groEL 3-13?? PLP 180-199 MOG 97-109 Mtb groEL 3-13 Mtb ESAT6 1-15? Mtb ESAT6 1-15 CEA 321-333 Rituximab Heavy chain 36-50 Rituximab Light chain 41-55 Infliximab Heavy chain 46-60 type II collagen (CII) 256-270 NY-ESO-1 157-165 (9C) Synthetic epitope PADRE M. tuberculosis CFP-10 71-85 Preproinsulin 76-90 88S HCV NS5a 1957-1975 SARS-CoV-2 Spike 236-250 EGF-R-479 350-359 MAGEA3 271-279 mTERT 572-580 EBV LMP-2 356-364 EBV LMP-2 340-349 HBV core 18-27 (subtype ADR4) HCV NS3 1435-1443 HCV core 35-44 HCV core 41-49 HCV NS3 1359-1367 Influenza A (PR8) Polymerase acidic protein 224-233 Mesothelin 530?538 miHAg HA-8 Non-muscle Myosin 478-486 MuLV env 622-629 SV40 T antigen 404-411 RSV A strain F protein 85-93 NRP-V7 superagonist peptide 8.3 Tg NOD mouse Non muscle Myosin-9 741-749 PSMA 27-38 ENV EBNA 3A 603?611 SIV Gag 71-79 SIV Nef 159-167 SIV Gag 181-189 PRAME 100-108 HCMV pp65 363-373 HCMV IE1 184-192 HCMV IE1 81-89 MCMV m164 257-265 EGF-R 1138-1147 EBV LMP2 200-208 Negative Control Prostatic acid phosphatase precursor (PAP) 299-307 HBV core 93-100 HCV NS3 1436-1444 HCV NS5B 2727-2735 HCV NS4b 1807-1816 HCV NS5a 1987-1995 HCV core 111-119 HCV NS3 1395-1403 HCV E1 207-214 HCV NS5a 2266-2275 HCV NS3 1629-1637 Adenovirus 5 Hexon 886-894 Adenovirus 5 Hexon 37-45 Adenovirus Hexon 114-124 T1D Diabetes human prepro islet amyloid polypeptide ppIAPP 5-13 T1D Diabetes IGRP 228?236 Insulin B chain 10-18 GAD65 114-123 Myelin basic protein 110-118 Human T-cell lymphotropic virus-1 Tax 11-19 Human T-cell lymphotropic virus-1 Tax 301-309 LCMV NP 396-404 LCMV GP1 33-41 LCMV GP 276-286 Listeria monocytogenes Listeriolysin 91-99 Plasmodium falciparum Liver stage antigen 1671-1679 Plasmodium falciparum CSP 334-342 Plasmodium berghei CSP 252-260 miHAg H-Y (human SMCY) 311-319 MiHAg SMCY 1041-1051 miHAg SMCY 738-746 miHAg UTY 246-254 Ovalbumin 257-264 Ovalbumin (subdominant) 55-62 E. coli beta-galactosidase 876-884 Enhanced Green Fluorescent Protein (eGFP) 200-208 RSV NP 137-145 Trypanosoma cruzi ASP-2 553-560 Trypanosoma cruzi SP 536-543 Mycobacterium tuberculosis Ag85A 70?78 Mycobacterium tuberculosis TB10.4 4-12 Mycobacterium tuberculosis ESAT-6 17-25 Vaccinia virus Copenhagen Protein G5 18-26 Vaccinia virus Host range protein 2 74-82 VSV N 275-283 VSV NP 52 West Nile Virus NY-99 polyprotein precursor (1452-1461) West Nile virus NY-99 polyprotein precursor 2023-2031 West Nile virus NY-99 polyprotein precursor 3390-3398 West Nile Virus polyprotein 294-302 Yellow Fever Virus 17D polyprotein 268-275 Telomerase Reverse Transcriptase (hTRT) 988-997 GPC3 298-306 HIV-1 Vif 101-109 HIV-1 Nef 137-145 HIV-1 Nef 134-143 HIV-1 HIV-1 RT 328-336 HIV-1 HIV-1 RT 273-282 Influenza A MP2 70-78 Influenza A MP1 178-187 Influenza A PB1 329-337 Influenza A NP 473-481 Influenza A PB1 591-599 Influenza A NP 383-391 Polyoma virus middle T protein 389-397 MuLV env gp70 423-431 T1D Diabetes IGRP 265-273 Chondromodulin-I 319-327 Topoisomerase II-alpha-b 828-836 Epithelial Discoidin Domain Receptor 1 (EDDR1) 867-876 VEGFR2/KDR fragment 1 614-624 Tyrosinase 369-377 (371D) gp100-intron 4 (170-178) Tyrosinase 243-251 (244S) Neu/Her-2/Erbb2 proto-oncoprotein 66-74 Receptor for hyaluronic acid?mediated motility (RHAMM) 165-173 Moloney murine sarcoma virus (MoMSV) GagL 85?93 Murine Survivin 20-28 Ewing Tumor EZH2 666-674 gp100 (pmel17) 25-33 p53 187-197 Survivin-3A 96-104 Telomerase Reverse Transcriptase (hTRT) 615-624 Prostate Stem Cell Antigen (PSCA) 105-133 p53 149-157 Prostate Specific Antigen-1 153-161 MCMV m45 985-993 EBV BZLF-1 54-64 EBV LMP-1 125-133 EBV EBNA-3C 881-889 HBV Surface antigen 190-197 HIV-1 IIIB gp120 318-327 HIV gag p24 223?231 HIV-1 US4 gp120 318-326 HPV 16 E7 49-57 HPV 33 E6 64-72 HPV 33 E7 5-13 HPV 16 E7 12-20 LCMV GP 118-125 Minor Histocompatibility Antigen HA-1 137-145 Synthetic variant of VSV Nucleoprotein 498?505 Histocompatibility antigen 60 39-46 Mycobacterium tuberculosis TB10.4 4-11 Vaccinia virus WR epitope B8R 20-27 BA46 (Lactadherin) 97-106 Survivin 80-88 SARS-CoV-2 Nucleocapsid protein 362-370 (confirmed epitope) Telomerase Reverse Transcriptase (hTRT) 674-683 BCR-ABL MAGEA5 5-12 gp100 (pmel) 209-217 p53 139-147 MAGEA3 112-120 (alternative version) Tumor Mucin Antigen 13-21 Tyrosinase 208-216 NY-ESO-1 94-102 Survivin-3A 18-27 (27K) p53 65-73 Lymphocyte antigen 6 complex locus K (LY6K) 177-186 Murine Survivin 97-104 gp100 (pmel) 280-288 (288V) p53 103-111 MAGEA2 157-166 Carcinoembryonic antigen (CEA)-derived peptide CAP1-6D EBV BALF-4 276?284 HCV NS5b 2594-2602 HIV-1 gp100 103-111 HTLV bZIP factor 42-50 Influenza A MP 59-68 LCMV envelope gp 10-18 LCMV envelope gp 447-455 EBV BMLF-1 259-267 Influenza A HA 533-541 HLA-A leader sequence peptide HPV16 E6 HPV 16 E6 18-26 VP1 100-108 VP1 36-44 gp33 (C9M) Plasmodium CSP Plasmodium berghei ANKA acid phosphatase 40-48 HA-2 tgd057 57-64 ESAT-6 16 kDa 19 kDa Mtb85A 145-152 IE62 593-601 NS4B 214-222 AdV Hexon Ad5 E1A 234?243 Proinsulin precursor 15-24 MOG Precursor 69-78 hPSA MAGE-A3 PRAME EphA2 P2X5 mTERT WT1 MAGE-A1 161-169 MAGE-A3 168-176 PRAME 425-433 gp100 PSA 65-73 MC28 adpgk neoantigen Human alfa fetoprotein 158-166 Insulin receptor substrate-2 1097-1105 Insulin receptor substrate 2 BKV Ltag 579-587 BKV Ltag 406-414 HPV E7 11-19 MC-38 HIV Pol MAGE-A4 230?239 MAGE-C1 1083-1091 Heme oxygenase-1 212-220 IRS-2 1097-1105 VEGFR2 400-408 Tyrosinase 368-376 IE1 199-207 pp65 15-23 pp65 120-128 BRLF1 EBNA3B 399-408 BRLF1 109?117 LMP1 159-167 NS5B 2841-2849 HIV env HIV nef HIV gag p24 197-205 HIV nef 84-92 HIV p24 gag 128-135 SIV gag HIV gag p24 HIV pol 325-333 ITGB8 662-670 ACPP 299-307 SSA SS-56 55-64 IL13R 345-353 Bcl-2 85-93 FAP alpha 463-471 RNF43 11-20 CB9L2 LAGE-1 46-54 TPBG 258-266 SART3 315-323 BMI1 271-279 WT1 235-243 CDH3 807-816 MiHA ACC1 15-23 PASD1 695-703 MELK 87-95 (93N) CA9 219-227 DEP DC1 294-302 SARS-CoV Nucleocapsid protein 223-231 (conserved in SARS-CoV-2) TARP(V28L)27-35 TARP(P5L) 5-13 FAP 639-647 TRAG-3 4-12 BRAF 594-601 (600E) BRAF 594-601 (600V) HENMT1 221-229 DLK1 309-317 HER-2 434-443 FOXM1 262-270 691-700 CEACAM 185-193 STEAP 292-300 (293L) 194-202 RNF43 721-729 (722Y) Bcl-2 208-217 PSCA 44-51 (51A) PASD1 39-48 HMOX1 145-153 165-173 SART3 309-317 RhoC 176-185 (177L) Mcl-1 95-103 131-139 WT-1 126-134 (Wilms tumor) Midkine 110-119 muFAP? 289-296 p31-39 TRAG-3 57-66 Mybpc2 295-302 PSMA 85-93 WT1 187-195 20-28 EZH2 729-737 TNPO3 TTK protein kinase 551-559 Mesothelin 429-437 BMI1 74-82 NY-ESO-1 127-136 KIF20A 67-75 IL13r 146-154 Bcl-2 214-223 TACE 250-258 CD33 65-73 (1Y2L) Bcl-X 173-182 BCL-2 180-189 Prominin1 744-752 PASD1 168-176 Osteocalcin 51-60 CMV IE-1 248-256 CMV IE-1 199-207 (R/L Position 3 M/I Position 7) HCMV IE1 316-324 (UL123) IA-2 797-805 IA-2 805-813 EBV EBNA-1 407-417(4A) EBV EBNA-3C 284-293 EBV BMRF1 116-128 EBV BMRF1 208-216 EBV EBNA-3A 458-466 DRRFY (1521-1529)) SMCY 1332-1339 VP1 108-116 Pol 502-510 HIV Vpu 66-74 Gag 433-440 HIV gag 79-86 HIV env 382-391 HIV gag 77-85 HIV Vif 23-31 Env 586-593 HPV L1 165-173 HPV E6 48-57 HPV 33E6 86-94 HSV p56 487-495 1116-1124 207-215 bZIP factor 26-34 bZIP factor 10-18 Flu BNP 85-94 (Influenza B) Influenza A polymerease PA 224-233 NP 69-77 MCMV m145 451-459 MCMV M139 419-426 MHV 524-431 Leptospira ASP-2 320-327 AAV VP1 492-500 AAV2 372-380 HSP90 alpha 280-288 (Pathologic Conditions) HSP105 234-243 HSP105 128-136 circadian clock protein PASD1 691-700 iLR1 59-68 CYP190 iLR1 MAGE-C2 191-200 MAGE-C2 336-344 MPP11 NPM1 Alpha-fetoprotein isoform 1 137-145 Alpha-fetoprotein isoform 2 167-176 HSP1A 459-467 HSP1A 461-469 Receptor tyrosine-protein kinase erbB-2 48-56 Genome Polyprotein EPHA2 550-558 STEAP 86-94 Chlamydia trachomatis MOMP 258-266 MOMP precursor 283-291 BIR TRAP 45-54 Alpha papillomavirus 9 E6 Protein (22-31) Mucin 79-87 RHAMM 275-283 Tyrosinase 243-251 X 92-100 CyclinD 101-109 Core 87-95 large envelope 362-371 IGRP (206-214) Mutant anaplastic lymphoma kinase 1220-1229 KRAS G12D (5-14) Receptor tyrosine-protein kinase erbB-2 728-736 Receptor tyrosine-protein kinase erbB-2 819-828 Core 19-27 KRAS G12V(5-14) HBV Pol 455-463 KRAS G12V(8-16) BIR7 90-99 Fibromodulin 250-259 Fibromodulin 206-215 Insulin Precursor 76-90 Trophoblast glycoprotein 17-25 Aspergillus fumigatus Crf1/p41 170-184 Influenza A MP 13-21 cyclin-dependent kinase 4 170-178 LT antigen 27-35 Dengue NS3 557-565 (Singapore/S275/1990) Dengue C 22-31 core protein 64-72 core protein 23-31 external core Ag Core 30-38 Core 141-151 Polymerase 548-556 Core 88-96 Streptococcus pyogenes Cas9 615-623 WNV nonstructural protein 4B 15-23 WNV envelope gp 430-438 NS3 205-213 large T antigen 398-406 large T antigen 410-418 Cysteine-rich membrane protein 63-71 Probable ATP-dependent Clp protease ATP-binding subunit 7-15 PqqC-like protein 70-78 POMP 612-620 pp65 211-219 IE1 88-95 IE1 309-317 NS3 serotype 1 133-142 Dengue NS3 serotype 2 133-142 Dengue NS3 serotype 3&4 133-142 Dengue NS3 133-142 Dengue NS3 500-508 Dengue NS3 serotype 2 222-231 Dengue C 107-115 Dengue NS2b 52-60 Dengue NS2b 97-106 Dengue NS3 25-32 Dengue NS5 375-383 Dengue NS3 112-120 Dengue NS3 64-74 Dengue NS4a 56-64 Dengue NS3 528-537 Dengue NS4a 6-13 Dengue NS4b 40-48 Dengue NS4b 111-119 Dengue NS3 422-431 Dengue NS5 563-571 Tyr A1a 454-463 MAGEA3 MAGE-A4 169x96177 PSMA N-ras 55-64 Cytochrome P450 240-249 Mcl-1 177x96185 AIM-2 Minor antigen HA-3T (Lbc oncogene 451-459) TRP-2 181-190 FLT3 ITD PSCA HER2 466-474 CEACAM5 687-695 HER-2/neu 789-797 MG50 624x96632 HCA587 317-325 FSP26 Tyrosinase 207-216 5T4 97x96105 TRP2 185-193(L) CSNK1A1 26-34 CSNK1A1 26-35 TRPM8 187-195 VEGFR1 28-37 TRAG-3L 58-66 Receptor tyrosine-protein kinase erbB-2 707-715 HAUS3 154-162 SSX2 41-49 MAGEA2 153-161 MAGEA3 220-228 LSP1 325-333 Tyrosinase precursor 224-233 PSCA 17-26 Fibromodulin 7-15 MG50 69-77 Mucin2 467-475 TRAP 59-68 SOX11 266-275 Ankyrin NYBR1 158-167 CAMEL 2-11 MAGEA3 160-169 MAGEA12 160-169 Mucin2 645-653 Receptor tyrosine-protein kinase erbB-2 437-445 PAX3/FKHR 135-143 Receptor tyrosine-protein kinase erbB-2 845-853 MG50 1244-1252 SSX2 103-111 CyclinD 228-236 Desmuslin 426-434 TRAP 57-65 GAS7 Neoepitope L-dopachrome tautomerase 288-296 O-linked N-acetylglucosamine transferase FSP06 SFRS2B 241-249 Receptor tyrosine-protein kinase erbB-2 448-456 MG50 210-218 BIR 7 230-239 Prostate stem cell antigen 4-13 MG50 625-633 Receptor tyrosine-protein kinase erbB-4 890-898 Tensin3 1558-1566 Receptor tyrosine-protein kinase erbB-2 743-751 MG50 1051-1059 Cytochrome P450 246-254 L-dopachrome tautomerase 488-496 CEA 176-185 Hepatocyte growth factor receptor 673-681 Dickkopf-related protein 1 20-29 FGFR4 676-684 Thymidylate synthase 231-240 MART-1 56-64 Heparanase 8-16 MAGEA9 223-231 hnRNP L 140-148 RNF43 11-19 Melanocyte-specific secreted glycoprotein 184-193 Tyrosinase 482-190 Melanocyte-specific secreted glycoprotein 20-28 MCL-1 139-147 hnRNP L 404-412 Heparanase 185-193 ETV5 54-53 Cyclin-dependent kinase inhibitor 1 97-105 ACTN4 118-127 (K5N) Tubulin beta 4 283-291 Malic enzyme 224-232 PLEKHM2 VP1 44-52 Norovirus VP1 139-148 SARS-CoV-2 ORF3a 139-147 (confirmed epitope) SARS-CoV-2 ORF1ab 3886-3894 (confirmed epitope) SARS-CoV-2 ORF3a 207-215 (confirmed epitope) SARS-CoV-2 Nucleocapsid protein 105-113 (confirmed epitope) SARS-CoV-2 Nucleocapsid protein 9-17 SARS-Cov-2 ORF1ab 4163-4172 Hepatitis A Virus polyprotein 2027-2034 Hepatitis A Virus polyprotein 1877-1885 SARS-CoV-2 Spike glycoprotein 691-699 DENV 1 NS5 2610-2618 DENV 3 NS5 2607-2615 DENV 2 NS5 2608-2616 DENV 2 NS3 1608-1617 DENV 4 NS3 1607-1617 DENV 2 Core 58-67 DENV 2 NS2a 1336-1344 DENV 2 Polyprotein 1863-1871 DENV 2 NS3 1863-1871 DENV 1 NS3 1864-1872 DENV 2 Polyprotein 2315-2323 DENV 3 NS5 2971-2980 DENV 1 4 NS5 2611-2619 DENV 2 NS5 2609-2617 DENV 3 NS5 2608-2616 DENV 2 M 261-269 Melanoma-associated antigen 4 (MAGE4) 113-121 SARS-CoV-2 Replicase polyprotein 1ab 1637-1646 (confirmed epitope) SARS-CoV-2 Replicase polyprotein 1ab 1621-1629 (confirmed epitope) SARS-CoV-2 Spike glycoprotein 1220-1228 (confirmed epitope) SARS-CoV Spike glycoprotein precursor 940-948 (conserved in SARS-CoV-2) SARS-CoV-2 Spike glycoprotein 996-1004 (confirmed epitope) SARS-CoV Spike glycoprotein precursor 1174-1182 (conserved in SARS-Cov-2) SARS-CoV Spike glycoprotein precursor 958-966 (conserved in SARS-Cov-2) SARS-Cov-2 Spike glycoprotein 269-277 (confirmed epitope) SARS-CoV-2 Nucleocapsid protein 322-330 (confirmed epitope) SARS-CoV-2 Spike glycoprotein 1000-1008 (confirmed subdominant epitope) PRAME (432-440) Wilms Tumor Protein 83-91 Melanoma-associated antigen 4 (MAGE4) 286-294 Membrane-associated transporter protein Endophilin-B2 244-252 KRAS G12D (7-16) KRAS G12V(7-16) EWS-FLI-1 oncogene Wilms Tumor protein (221- 229) EBNA-1 (562-570) LMP2_EBVG 339-348 Rabies Glycoprotein (453-461) SARS-CoV-2 Spike Protein (S) 417-425 Spike 349-357 Spike 505-523 GAD2 339-352 isocitrate dehydrogenase [NADP] cytoplasmic (IDH1)(123-142) TERT UPC2 (578-592) Factor VIII Mimotop of Chain A Histocompatibility Antigen I-Ag7 from Mus Musculus Chain A. SARS-CoV2 Spike Protein (S) 166-180 Mimotope of Chain A Lymphocytic choriomeningitis virus glycoprotein 6-20 Lymphocytic choriomeningitis virus glycoprotein 316-330 Lymphocytic choriomeningitis virus nucleoprotein 176-190 Lymphocytic choriomeningitis virus nucleoprotein 466-480 Listeriolysin O precursor 190-201 chicken ovalbumin 329-337 I-E alpha chain (2W1S) 52-68 Mouse myelin oligodendrocyte glycoprotein 38-49 mouse MBP 63-74 murine class II-associated invariant chain peptide (CLIP) 86-100 Human class II-associated invariant chain peptide (CLIP) 103-117 Respiratory syncytial virus matrix protein M 209-223 Respiratory syncytial virus matrix protein 2 26-39 M. tuberculosis antigen 85B precursor 280-294 M. tuberculosis RplJ 140-164 West Nile Virus envelope protein 641-655 DBY 608-622 Human clotting factor VIII 2210-2229 Helicobacter hepaticus HH1713 230-244 Influenza A nucleocapsid protein 311-325 Lymphocytic choriomeningitis virus glycoprotein 66-77 HCV NS3 1535-1551 mouse ProInsulin 47-64 IAd LCMV NP 116-130 (P8) SARS-CoV-2 Env 56-70 IAd LCMV NP 86-100 IAd Influenza A M2 2-17 IAd Influenza A HA 141-155 IAd Influenza A HA 143-155 MOG 38-49 var V47A MOG 38-49 var S42P Chicken ovalbumin 323-339 SARS-CoV S protein (939-955)(conserved in SARS-CoV2) SARS-CoV S protein (993-1010) (conserved in SARS-CoV2) SARS-CoV S protein (884-899) (conserved in SARS-CoV2) SARS-CoV S protein (873-888) (conserved in SARS-CoV2) SARS-CoV-2 ORF1ab 2211-2225 SARS-CoV-2 gp 176-190 SARS-CoV-2 ORF1ab 3948-3962 SARS-CoV-2 ORF1ab 1641-1651 SARS-CoV-2 ORF1ab 808-816 SARS-CoV-2 Spike glycoprotein 448-456 SARS-CoV-2 Spike glycoprotein 1205-1213 SARS-CoV-2 ORF7a 78-86 SARS-CoV-2 Spike glycoprotein 378-386 SARS-CoV-2ÿ Membrane glycoprotein 172-188? SARS-CoV-2 Spike glycoprotein 866-880 SARS-CoV-2 Spike glycoprotein 751-765 SARS-CoV-2 Spike glycoprotein 751-767 HIV Env gp 67-7 SARS-CoV-2 ORF1ab 5724-5732 SARS-CoV-2 ORF1ab 5455-5463 SARS-CoV-2 ORF1ab 5563-5571 SARS-CoV-2 ORF1ab 5781-5789 Synthetic variant of VSV Nucleoprotein 498–505 EBV BALF-4 276–284 Ad5 E1A 234–243 MAGE-A4 169–177 Mcl-1 177–185 MG50 624–632 5T4 97–105 PRAME PRA 300–309 EBV LMP2 419–427 Leukocyte Proteinase-3 (Wegener's autoantigen) 169-177 HER-2/neu (85–94) Mesothelin 530–538 ENV EBNA 3A 603–611 T1D Diabetes IGRP 228–236 Mycobacterium tuberculosis Ag85A 70–78 Receptor for hyaluronic acid–mediated motility (RHAMM) 165-173 Moloney murine sarcoma virus (MoMSV) GagL 85–93 HIV gag p24 223–231 MAGE-A4 230–239 BRLF1 109–117 HBV core 60-75 Influenza A nucleocapsid protein 311-325 SARS-CoV-2ÿ Membrane glycoprotein 172-188? KMT2A / pMLL 747-755 2C TCR HIV NEF 143-152 |
Show products per page
Page 1 of 1
| Allele | Peptide Code | Peptide Sequence | Application | Epitope Origin | Configuration | Qty | Price | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| No product found. | |||||||||||
Loading Products | |||||||||||
×
![]()